Free Trial

Kindly MD (KDLY) Competitors

Kindly MD logo
$10.09 -0.53 (-4.99%)
As of 08/20/2025

KDLY vs. XGN, CORBF, DCGO, EUDA, SERA, QIPT, BNR, NAKA, ATPC, and BDSX

Should you be buying Kindly MD stock or one of its competitors? The main competitors of Kindly MD include Exagen (XGN), Global Cord Blood (CORBF), DocGo (DCGO), EUDA Health (EUDA), Sera Prognostics (SERA), Quipt Home Medical (QIPT), Burning Rock Biotech (BNR), KindlyMD (NAKA), Agape ATP (ATPC), and Biodesix (BDSX). These companies are all part of the "healthcare" industry.

Kindly MD vs. Its Competitors

Kindly MD (NASDAQ:KDLY) and Exagen (NASDAQ:XGN) are both small-cap medical companies, but which is the better business? We will contrast the two companies based on the strength of their analyst recommendations, earnings, institutional ownership, risk, dividends, media sentiment, valuation and profitability.

Kindly MD has a net margin of 0.00% compared to Exagen's net margin of -28.85%. Kindly MD's return on equity of 0.00% beat Exagen's return on equity.

Company Net Margins Return on Equity Return on Assets
Kindly MDN/A N/A N/A
Exagen -28.85%-130.38%-34.69%

Exagen has a consensus price target of $11.25, suggesting a potential upside of 12.73%. Given Exagen's stronger consensus rating and higher possible upside, analysts plainly believe Exagen is more favorable than Kindly MD.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Kindly MD
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00
Exagen
0 Sell rating(s)
0 Hold rating(s)
7 Buy rating(s)
0 Strong Buy rating(s)
3.00

In the previous week, Exagen had 1 more articles in the media than Kindly MD. MarketBeat recorded 3 mentions for Exagen and 2 mentions for Kindly MD. Kindly MD's average media sentiment score of 1.47 beat Exagen's score of 0.49 indicating that Kindly MD is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Kindly MD
2 Very Positive mention(s)
0 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Exagen
2 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral

75.3% of Exagen shares are held by institutional investors. 50.5% of Kindly MD shares are held by insiders. Comparatively, 12.6% of Exagen shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.

Kindly MD has higher earnings, but lower revenue than Exagen. Kindly MD is trading at a lower price-to-earnings ratio than Exagen, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Kindly MD$2.47M24.60-$4.64M-$0.77-13.10
Exagen$55.64M3.95-$15.11M-$0.89-11.21

Summary

Kindly MD beats Exagen on 8 of the 15 factors compared between the two stocks.

Get Kindly MD News Delivered to You Automatically

Sign up to receive the latest news and ratings for KDLY and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding KDLY and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

KDLY vs. The Competition

MetricKindly MDHealth services IndustryMedical SectorNASDAQ Exchange
Market Cap$60.76M$70.06M$5.74B$9.56B
Dividend YieldN/AN/A4.53%4.08%
P/E Ratio-13.10N/A30.4525.16
Price / Sales24.608.99392.5887.64
Price / CashN/A4.0237.0358.50
Price / BookN/A1.158.956.21
Net Income-$4.64M-$30.80M$3.26B$265.38M
7 Day Performance-23.85%-11.92%1.06%-1.13%
1 Month Performance-8.44%-4.22%4.31%-0.71%
1 Year Performance483.24%483.24%28.40%18.89%

Kindly MD Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
KDLY
Kindly MD
N/A$10.09
-5.0%
N/A+519.5%$60.76M$2.47M-13.10N/ANews Coverage
Positive News
Gap Down
XGN
Exagen
3.5635 of 5 stars
$9.38
+2.0%
$11.25
+19.9%
+226.9%$202.43M$55.64M-10.54220Short Interest ↑
CORBF
Global Cord Blood
N/A$1.35
flat
N/A-14.3%$164.09M$196.12M0.001,200
DCGO
DocGo
2.1405 of 5 stars
$1.53
-2.5%
$3.56
+132.7%
-54.3%$160.11M$616.55M-8.054,407Analyst Forecast
EUDA
EUDA Health
0.7685 of 5 stars
$2.52
-3.4%
N/A-54.5%$96.98M$4.01M0.002Gap Up
SERA
Sera Prognostics
0.8214 of 5 stars
$2.34
-5.6%
N/A-68.1%$93.43M$80K-2.75120News Coverage
QIPT
Quipt Home Medical
3.3158 of 5 stars
$2.12
-0.5%
$2.85
+34.4%
-17.0%$92.54M$245.91M-10.091,200Analyst Forecast
BNR
Burning Rock Biotech
0.3672 of 5 stars
$6.94
+1.8%
N/A+40.9%$73.39M$70.67M-3.671,390News Coverage
Upcoming Earnings
Gap Down
NAKA
KindlyMD
N/A$14.28
+49.2%
N/AN/A$72.79M$2.72M-16.60N/AHigh Trading Volume
ATPC
Agape ATP
0.0968 of 5 stars
$1.36
-0.4%
N/A-36.1%$68.26M$1.32M-2.2740News Coverage
Short Interest ↑
BDSX
Biodesix
3.1274 of 5 stars
$0.39
-2.5%
$1.75
+348.4%
-76.4%$58.70M$71.32M-1.35220

Related Companies and Tools


This page (NASDAQ:KDLY) was last updated on 8/21/2025 by MarketBeat.com Staff
From Our Partners